Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 286

The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.

The allergy mediator histamine confers resistance to immunotherapy in cancer patients via activation of the macrophage histamine receptor H1

Open access
Li, Hongzhong, Xiao, Yi, Li, Qin, Yao, Jun, Yuan, Xiangliang, Zhang, Yuan, Yin, Xuedong, Saito, Yohei, Fan, Huihui, Li, Ping, Kuo, Wen-Ling, Halpin, Angela, Gibbons, Don L., Yagita, Hideo, Zhao, Zhongming, Pang, Da, Ren, Guosheng, Yee, Cassian, Lee, J. Jack, Yu, Dihua·2022·Cancer Cell

Abstract

SUMMARY Reinvigoration of anti-tumor immunity remains an unmet challenge. Our retrospective analyses revealed that cancer patients who took antihistamines during immunotherapy treatment had significantly improved survival. We uncovered that histamine and histamine receptor H1 (HRH1) are frequently increased in the tumor microenvironment and induce T cell dysfunction. Mechanistically, HRH1-activated macrophages polarize toward an M2-like immunosuppressive phenotype with increased expression of the immune checkpoint VISTA, rendering T cells dysfunctional. HRH1 knockout or antihistamine treatment reverted macrophages immunosuppression, revitalized T cell cytotoxic function, and restored immunotherapy response. Allergy, via the histamine-HRH1 axis, facilitated tumor growth and induced immunotherapy resistance in mice and humans. Importantly, cancer patients with low plasma histamine levels had more than tripled objective response rate to anti-PD-1 treatment compared to patients with high plasma histamine. Altogether, pre-existing allergy or high histamine levels in cancer patients can dampen immunotherapy responses and warrant prospectively exploring antihistamines as adjuvant agents for combinatorial immunotherapy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ccell.2021.11.002

Cites

59 of 59 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 59 references

Cited by

See all 286

Metadata

Authors
Li, H., Xiao, Y., Li, Q., Yao, J., Yuan, X., Zhang, Y., Yin, X., Saito, Y., Fan, H., Li, P., Kuo, W.-L., Halpin, A., Gibbons, D. L., Yagita, H., Zhao, Z., Pang, D., Ren, G., Yee, C., Lee, J. J., & Yu, D.
Venue
Cancer Cell
Publisher
Elsevier BV
Published
2022-01
Volume
40
Issue
1
Pages
36-52.e9
ISSN
1535-6108 (ISSN-L)
OpenAlex
W3215077655
Cited by
286
References
59
FWCI
14.92
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The allergy mediator histamine confers resistance to immunotherapy in cancer patients via activation of the macrophage histamine receptor H1. https://app.cochat.ai/papers/10.1016/j.ccell.2021.11.002
The paper
Li, H., Xiao, Y., Li, Q., Yao, J., Yuan, X., Zhang, Y., Yin, X., Saito, Y., Fan, H., Li, P., Kuo, W.-L., Halpin, A., Gibbons, D. L., Yagita, H., Zhao, Z., Pang, D., Ren, G., Yee, C., Lee, J. J., & Yu, D. (2022). The allergy mediator histamine confers resistance to immunotherapy in cancer patients via activation of the macrophage histamine receptor H1. Cancer Cell. https://doi.org/10.1016/j.ccell.2021.11.002

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.